Sodium Hydroxide → HCID 66660124, compound
Reaction equation
[C:1]([O:5][C:6]([NH:8][C@H:9]1[CH2:14][N:13]([C:15]2[N:20]=[C:19]([CH3:21])[CH:18]=[C:17]([NH:22][C:23]3[NH:27][N:26]=[CH:25][CH:24]=3)[N:16]=2)[CH2:12][C@@H:11]([C:28]([O:30]C)=[O:29])[CH2:10]1)=[O:7])([CH3:4])([CH3:3])[CH3:2].[OH-].[Na+].[NH4+].[Cl-]>CO>[C:1]([O:5][C:6]([NH:8][C@@H:9]1[CH2:14][N:13]([C:15]2[N:20]=[C:19]([CH3:21])[CH:18]=[C:17]([NH:22][C:23]3[NH:27][N:26]=[CH:25][CH:24]=3)[N:16]=2)[CH2:12][C@@H:11]([C:28]([OH:30])=[O:29])[CH2:10]1)=[O:7])([CH3:4])([CH3:2])[CH3:3]Participants
5
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
The crude carbamate was dissolved into MeOH (4 ml). 2 M aqueous solution of NaOH was added at room temperature. And the mixture was stirred at room temperature for 4 hours. After the addition of NH4Cl for neutrallization, the resulting reaction mixture was concentrated in vacuo. The residue was suspended into the mixed solvent of CHCl3/MeOH. The insoluble material was filtered off and the filtrate was concentrated again. The residue was purified with silica gel PTLC (eluent: CHCl3/MeOH=6/1) to give trans-5-[(tert-butoxycarbonyl)amino]-1-[4-methyl-6-(1H-pyrazol-5-ylamino)pyrimidin-2-yl]piperidine-3-carboxylic acid (10.9 mg) as colorless solid.
Workup
- customthe resulting reaction mixture
- concentrationwas concentrated in vacuo
- filtrationThe insoluble material was filtered off
- concentrationthe filtrate was concentrated again
- customThe residue was purified with silica gel PTLC (eluent: CHCl3/MeOH=6/1)
Sources & evidence
- ORD record
- ord-c6747fea4d794154a3b2cabd2abfe77b
- Source dataset
- uspto-grants-2013_02
- Patent number
- US08367690B2
Reaction notes
Loading…